First Horizon Advisors Inc. Has $4.22 Million Position in Agilent Technologies, Inc. (NYSE:A)

First Horizon Advisors Inc. reduced its position in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 15.5% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 28,433 shares of the medical research company's stock after selling 5,227 shares during the period. First Horizon Advisors Inc.'s holdings in Agilent Technologies were worth $4,222,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Crewe Advisors LLC lifted its position in shares of Agilent Technologies by 114.8% in the 2nd quarter. Crewe Advisors LLC now owns 189 shares of the medical research company's stock worth $25,000 after purchasing an additional 101 shares during the period. Livelsberger Financial Advisory acquired a new position in shares of Agilent Technologies in the 3rd quarter valued at about $28,000. Ridgewood Investments LLC acquired a new stake in Agilent Technologies during the second quarter worth approximately $29,000. Ashton Thomas Securities LLC acquired a new position in Agilent Technologies in the third quarter valued at approximately $31,000. Finally, Fortitude Family Office LLC lifted its position in shares of Agilent Technologies by 68.3% during the 3rd quarter. Fortitude Family Office LLC now owns 234 shares of the medical research company's stock valued at $35,000 after acquiring an additional 95 shares during the period.

Wall Street Analyst Weigh In

Several analysts recently issued reports on A shares. Stifel Nicolaus reissued a "buy" rating and issued a $151.00 price target on shares of Agilent Technologies in a research report on Monday, August 26th. Bank of America raised their target price on Agilent Technologies from $140.00 to $147.00 and gave the company a "neutral" rating in a report on Thursday, August 22nd. Citigroup increased their price target on Agilent Technologies from $150.00 to $165.00 and gave the company a "buy" rating in a research report on Thursday, August 22nd. Barclays raised their price objective on Agilent Technologies from $135.00 to $145.00 and gave the company an "underweight" rating in a research note on Tuesday, October 15th. Finally, Wells Fargo & Company assumed coverage on shares of Agilent Technologies in a report on Tuesday, August 27th. They issued an "overweight" rating and a $157.00 target price for the company. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and nine have assigned a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $144.36.

Agilent Technologies Price Performance

Agilent Technologies stock opened at $128.57 on Thursday. The firm has a market capitalization of $36.94 billion, a P/E ratio of 26.67, a PEG ratio of 5.59 and a beta of 1.07. Agilent Technologies, Inc. has a one year low of $121.23 and a one year high of $155.35. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.78 and a quick ratio of 1.37. The business has a fifty day moving average price of $138.06 and a 200-day moving average price of $137.76.

Agilent Technologies (NYSE:A - Get Free Report) last announced its quarterly earnings results on Wednesday, August 21st. The medical research company reported $1.32 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.26 by $0.06. The firm had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.56 billion. Agilent Technologies had a net margin of 21.75% and a return on equity of 25.26%. The company's revenue for the quarter was down 5.6% on a year-over-year basis. During the same period in the prior year, the firm posted $1.43 earnings per share. As a group, equities research analysts forecast that Agilent Technologies, Inc. will post 5.24 EPS for the current year.

Agilent Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, October 23rd. Stockholders of record on Tuesday, October 1st were given a dividend of $0.236 per share. The ex-dividend date was Tuesday, October 1st. This represents a $0.94 dividend on an annualized basis and a dividend yield of 0.73%. Agilent Technologies's dividend payout ratio (DPR) is currently 19.50%.

Insider Transactions at Agilent Technologies

In other news, SVP Dominique Grau sold 9,990 shares of the business's stock in a transaction dated Thursday, September 26th. The stock was sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the completion of the transaction, the senior vice president now owns 40,011 shares of the company's stock, valued at approximately $5,801,595. The trade was a 19.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.